SK bioscience Announces Approval of Its Quadrivalent Influenza Vaccine in Indonesia
This approval paves the way for exports to the world's fourth most populous country. SK bioscience aims to continue to grow as a global vaccine brand beyond Korea. SEONGNAM, South Korea, Oct. 23, 2024 /PRNewswire/ -- SK bioscience, a global innovative vaccine and biotech company committed to promoting human health...
Samsung Biologics reports third quarter 2024 financial results
Recorded Q3'24 consolidated revenue of KRW 1.2 trillion Recorded Q3'24 consolidated operating profit of KRW 338.6 billion Continued business expansion through strong competitive edge in speed and execution INCHEON, South Korea, Oct. 23, 2024 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced...
Halloween 2024: Wisesky Drives New Trend of Healthy Living with Early Bird Black Friday Deal on Its Advanced W-Cat Air Purifier Designed Specifically for Cats
LOS ANGELES, Oct. 23, 2024 /PRNewswire/ -- Wisesky, an innovative brand that focuses on air purification technology and is committed to solving the problems faced by pet-raising families, is celebrating Halloween 2024 with the launch of an early bird Black Friday discount on its advanced W-Cat air purifier designed specifically for cats. With health technology making steady inroads into...
Australia’s Healthcare Innovators in Stroke and Paediatric Care Honoured at 2024 Challenger Summit
Life sciences investor Proto Axiom awards $250,000 in prizes at inaugural Summit SYDNEY, Oct. 23, 2024 /PRNewswire/ -- The 2024 Challenger Summit concluded with two visionary researchers recognised for their groundbreaking contributions to treatment of stroke and paediatric skin care. The Summit, a prestigious gathering of leading minds in medical research, was a platform for ideas and solutions that have...
AIMed 2024: A Pioneer in Healthcare Innovation to Join Key AI in Medicine Event
SAN ANTONIO, Oct. 23, 2024 /PRNewswire/ -- Frost & Sullivan proudly announce that Reenita Das, Partner and Senior Vice President of Healthcare & Life Sciences, will attend the highly anticipated AIMed 2024 Global Summit. The event, held from November 17 - 19, 2024, 2024, will bring together healthcare leaders and AI innovators from across the globe at Caribe Royale Orlando...
Harnessing Generative AI in Healthcare and Improving Cardiometabolic Health with Precision Medicine: Key Opportunities and Insights
HOUSTON, Oct. 22, 2024 /PRNewswire/ -- In today's rapidly evolving healthcare landscape, two powerful forces are reshaping how we diagnose, treat, and manage health conditions: Generative artificial intelligence (GenAI) and precision medicine for cardiometabolic health. GenAI promises to revolutionize operational efficiency, financial workflows, and clinical outcomes, while advancements in cardiometabolic treatments pave the way for personalized, patient-centered care. However,...
Nisun International Enters Strategic Partnership with Beijing Tong Ren Tang to Source Traditional Chinese Medicine Ingredients
Company Initiates Share Repurchases Under $15 Million Buyback Program SHANGHAI, Oct. 22, 2024 /PRNewswire/ -- Nisun International Enterprise Development Group Co., Ltd. ("Nisun International" or the "Company") (Nasdaq: NISN), a technology and industry driven integrated supply chain solutions provider, has signed a strategic cooperation agreement with Beijing Tong Ren Tang Henan Traditional Chinese Medicine Technology Development Co., Ltd., marking its...
Bloomage ‘YunZhong (In Cloud) Public Welfare’ Campaign: A 14-Year Journey of Cultural Preservation and Sustainability
PARSIPPANY, N.J., Oct. 22, 2024 /PRNewswire/ -- Bloomage, a global leader in the research, development, production, and sale of hyaluronic acid and other bioactive substances, continues to showcase its leadership in Environmental, Social, and Governance (ESG) initiatives. The company's YunZhong (In Cloud) Public Welfare campaign, which has been held for over 14 years, focuses on preserving fading cultures alongside...
Telix Spins Off Rhine Pharma™ to Expand Global Access to Radiopharmaceuticals
MELBOURNE, Australia, Oct. 22, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces the spin-off of Rhine Pharma, which has the mission of expanding global access to innovative radiopharmaceuticals for cancer imaging and treatment using two generator-produced isotopes, technetium-99m (99mTc) and rhenium-188 (188Re). Rhine Pharma was formed following...
Minghui Pharmaceutical Inc. Announces Positive Topline Results from Phase Ib/II Clinical Trial of MHB018A, a Subcutaneous Single-Domain IGF-1R Antibody, in Patients with Active, Moderate-to-Severe Thyroid Eye Disease (TED)
SHANGHAI, Oct. 22, 2024 /PRNewswire/ -- Minghui Pharmaceutical, Inc., a late-stage biopharmaceutical company dedicated to developing transformative medicines in immunology and oncology, today announced positive topline results from its Phase Ib/II clinical trial of MHB018A in patients with active TED. MHB018A is a novel subcutaneous VHH-Fc fusion protein that targets the insulin-like growth factor-1 receptor (IGF-1R), a validated...
